Featured Article
Genomic surveillance needs to be mobilized to ensure the world is prepared for future health threats from infectious diseases and antimicrobial resistance, experts maintain.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Vitamin D May Improve Cancer Immunity by Altering the Gut Microbiome
Researchers have discovered that vitamin D can increase the amount of a certain type of gut bacteria, providing better immunity to cancer.
Do COVID-19 mRNA Vaccines Boost Mucosal Immunity?
New evidence finds COVID-19 mRNA vaccines don’t provide much mucosal immunity, which suggests that new approaches, such as vaccines or adjuvants delivered to the respiratory system, may be needed to improve prevention efforts.
Pandemic Preparedness Needs Genomic Surveillance
Genomic surveillance needs to be mobilized to ensure the world is prepared for future health threats from infectious diseases and antimicrobial resistance, experts maintain.
